Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Colilen IBS
- Development stage
- Unknown
- Lead developer
- Aboca
- Modality
- Device-based Delivery → Drug Delivery Systems, Small Molecules
- Administration
- Oral
01
Overview
Colilen IBS is an oral product developed for the treatment and management of irritable bowel syndrome (IBS), featuring a patented molecular complex called ActiMucin, which is composed of resins (from Frankincense), polysaccharides (from Aloe vera), and polyphenols (from Chamomile and Lemon Balm). The mechanism relies on a physical-chemical barrier: ActiMucin interacts with the intestinal mucosa to form a protective film that shields mucosal tissue from contact with irritants and helps to normalize intestinal permeability. This mechanism is non-systemic and aims to reduce symptoms including pain, bloating, and irregular bowel movements. Colilen IBS is not a pharmaceutical drug in the classical sense but is marketed as a dietary supplement/medical device for symptomatic relief in IBS[1][2][4][5].
- Brand names
- Colilen IBS
Beyond the preview
Go deeper on Colilen IBS.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Colilen IBS.